Quantbot Technologies LP lifted its holdings in WisdomTree, Inc. (NYSE:WT – Free Report) by 586.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 250,017 shares of the company’s stock after purchasing an additional 213,571 shares during the quarter. Quantbot Technologies LP owned 0.17% of WisdomTree worth $2,498,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently modified their holdings of the company. CWM LLC increased its position in WisdomTree by 85.8% during the second quarter. CWM LLC now owns 2,746 shares of the company’s stock valued at $27,000 after acquiring an additional 1,268 shares during the last quarter. Headlands Technologies LLC purchased a new stake in WisdomTree during the second quarter valued at $27,000. Gladius Capital Management LP purchased a new stake in WisdomTree during the second quarter valued at $32,000. GAMMA Investing LLC increased its position in WisdomTree by 76.8% during the third quarter. GAMMA Investing LLC now owns 4,054 shares of the company’s stock valued at $40,000 after acquiring an additional 1,761 shares during the last quarter. Finally, Bayesian Capital Management LP purchased a new stake in WisdomTree during the first quarter valued at $105,000. Hedge funds and other institutional investors own 78.64% of the company’s stock.
Insider Transactions at WisdomTree
In related news, insider Peter M. Ziemba sold 100,000 shares of the stock in a transaction that occurred on Friday, November 15th. The stock was sold at an average price of $11.43, for a total transaction of $1,143,000.00. Following the completion of the transaction, the insider now directly owns 948,386 shares of the company’s stock, valued at approximately $10,840,051.98. This represents a 9.54 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Jonathan L. Steinberg purchased 67,869 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were purchased at an average cost of $10.84 per share, with a total value of $735,699.96. Following the completion of the purchase, the chief executive officer now owns 9,240,707 shares of the company’s stock, valued at $100,169,263.88. The trade was a 0.74 % increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 7.80% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Stock Analysis on WT
WisdomTree Stock Performance
NYSE WT opened at $11.76 on Thursday. The firm has a market cap of $1.72 billion, a price-to-earnings ratio of 40.55 and a beta of 1.43. The company has a quick ratio of 2.16, a current ratio of 2.88 and a debt-to-equity ratio of 1.36. The business has a 50-day moving average price of $10.55 and a 200-day moving average price of $10.19. WisdomTree, Inc. has a twelve month low of $6.24 and a twelve month high of $12.45.
WisdomTree Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, November 20th. Stockholders of record on Wednesday, November 6th were paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date was Wednesday, November 6th. WisdomTree’s dividend payout ratio (DPR) is 41.38%.
About WisdomTree
WisdomTree, Inc, through its subsidiaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. The company also licenses its indexes to third parties for proprietary products, as well as offers a platform to promote the use of WisdomTree ETFs in 401(k) plans.
See Also
- Five stocks we like better than WisdomTree
- What is the Dow Jones Industrial Average (DJIA)?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What is the Nasdaq? Complete Overview with History
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Ride Out The Recession With These Dividend KingsĀ
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for WisdomTree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree and related companies with MarketBeat.com's FREE daily email newsletter.